Yost R - Search Results

1

Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index.

McConachie SM, Raub JN, Yost R, Monday L, Agrawal S, Tannous P. McConachie SM, et al. Among authors: yost r. Am J Health Syst Pharm. 2020 Jun 4;77(12):950-957. doi: 10.1093/ajhp/zxaa078. Am J Health Syst Pharm. 2020. PMID: 32382749

2

Development of an iterative validation process for a 30-day hospital readmission prediction index.

McConachie SM, Raub JN, Trupianio D, Yost R. McConachie SM, et al. Among authors: yost r. Am J Health Syst Pharm. 2019 Mar 19;76(7):444-452. doi: 10.1093/ajhp/zxy086. Am J Health Syst Pharm. 2019. PMID: 31361819

3

Derivation and validation of a hospital all-cause 30-day readmission index.

Franckowiak TM, Raub JN, Yost R. Franckowiak TM, et al. Among authors: yost r. Am J Health Syst Pharm. 2019 Mar 19;76(7):436-443. doi: 10.1093/ajhp/zxy085. Am J Health Syst Pharm. 2019. PMID: 31361822

4

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.

Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, Pogue JM, Rybak MJ. Finch NA, et al. Among authors: yost r. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01293-17. doi: 10.1128/AAC.01293-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28923869 Free PMC article.

5

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction.

Hanni C, Petrovitch E, Ali M, Gibson W, Giuliano C, Holzhausen J, Makowski C, Pallisco A, Patel N, Sutter D, To L, Yost R. Hanni C, et al. Among authors: yost r. Blood Adv. 2020 Jun 9;4(11):2366-2371. doi: 10.1182/bloodadvances.2019000972. Blood Adv. 2020. PMID: 32463871 Free PMC article.

6

Azithromycin and Septic Shock Outcomes.

Johnson JM, Yost RJ, Pangrazzi MH, Golden KA, Soubani AO, Wahby KA. Johnson JM, et al. J Pharm Pract. 2023 Jun;36(3):559-565. doi: 10.1177/08971900211064193. Epub 2021 Dec 30. J Pharm Pract. 2023. PMID: 34967253

7

Conducting Multicenter Residency Research.

Giuliano C, Haan B, Hanni C, Ng TH, Yost R. Giuliano C, et al. Among authors: yost r. J Pharm Pract. 2023 Dec;36(6):1472-1479. doi: 10.1177/08971900221116191. Epub 2022 Jul 18. J Pharm Pract. 2023. PMID: 35848055 Review.

8

The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.

Yost RJ, Cappelletty DM; RECEIPT Study group. Yost RJ, et al. Pharmacotherapy. 2011 Aug;31(8):767-75. doi: 10.1592/phco.31.8.767. Pharmacotherapy. 2011. PMID: 21923603

9

Increased Enoxaparin Dosing Requirements for Treatment of Deep Vein Thrombosis in a Severely Burned Patient: Case Report and Literature Review.

Yost RJ, Haan BJ, Mangan KC. Yost RJ, et al. Pharmacotherapy. 2018 Nov;38(11):e82-e86. doi: 10.1002/phar.2176. Epub 2018 Sep 16. Pharmacotherapy. 2018. PMID: 30129107

10

A Comment on a Meta-analysis That Suggests Efficacy of Albumin in Burn Shock Resuscitation.

Yost R. Yost R. J Burn Care Res. 2017 Sep/Oct;38(5):e882. doi: 10.1097/BCR.0000000000000421. J Burn Care Res. 2017. PMID: 27606551 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters